Report of the Paris consensus meeting on expanded criteria donors in liver transplantation

Francoz, 2007, Indications of liver transplantation in patients with complications of cirrhosis, Best Pract Res Clin Gastroenterol, 21, 175, 10.1016/j.bpg.2006.07.007

Neuberger, 2004, Developments in liver transplantation, Gut, 53, 759, 10.1136/gut.2003.024927

Adam, 2000, Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study, Lancet, 356, 621, 10.1016/S0140-6736(00)02603-9

Foster, 2007, Expanding donor options: marginal, living, and split donors, Clin Liver Dis, 11, 417, 10.1016/j.cld.2007.04.004

Barshes, 2007, Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers, Am J Transplant, 7, 1265, 10.1111/j.1600-6143.2007.01758.x

Tector, 2006, Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival, Ann Surg, 244, 439, 10.1097/01.sla.0000234896.18207.fa

Alkofer, 2006, Extended-donor criteria liver allografts, Semin Liver Dis, 26, 221, 10.1055/s-2006-947292

Feng, 2006, Characteristics associated with liver graft failure: the concept of a donor risk index, Am J Transplant, 6, 783, 10.1111/j.1600-6143.2006.01242.x

2005, Workgroup on expanded criteria organs for liver transplantation, Liver Transpl, 11, 1184, 10.1002/lt.20569

Lucidi, 2007, Use of marginal donors for liver transplantation: a single-center experience within the Eurotransplant patient-driven allocation system, Transplant Proc, 39, 2668, 10.1016/j.transproceed.2007.08.004

Silberhumer, 2007, Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis, Transplantation, 83, 588, 10.1097/01.tp.0000255319.07499.b7

Renz, 2005, Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation, Ann Surg, 242, 556, 10.1097/01.sla.0000183973.49899.b1

Cameron, 2005, AASLD/ILTS transplant course: is there an extended donor suitable for everyone?, Liver Transpl, 11, S2, 10.1002/lt.20596

United Network for Organ Sharing http://www.unos.org 2008

Wood, 2004, Care of the potential organ donor, N Engl J Med, 351, 2730, 10.1056/NEJMra013103

Wilhelm, 2000, Brain death and its impact on the donor heart-lessons from animal models, J Heart Lung Transplant, 19, 414, 10.1016/S1053-2498(00)00073-5

Boulard, 2005, Management of subjects in a state of brain death and the preservation of organs, Ann Fr Anesth Reanim, 24, 836, 10.1016/j.annfar.2005.05.020

Lutz-Dettinger, 2001, Care of the potential pediatric organ donor, Pediatr Clin North Am, 48, 715, 10.1016/S0031-3955(05)70336-9

Rosendale, 2003, Hormonal resuscitation yields more transplanted hearts, with improved early function, Transplantation, 75, 1336, 10.1097/01.TP.0000062839.58826.6D

Salim, 2001, The role of thyroid hormone administration in potential organ donors, Arch Surg, 136, 1377, 10.1001/archsurg.136.12.1377

Khan, 2005, A prospective randomized trial of N-acetyl cysteine administration during cold preservation of the donor liver for transplantation, Ann Hepatol, 4, 121, 10.1016/S1665-2681(19)32075-7

Zhang, 2005, Protective effects of glycine pretreatment on brain-death donor liver, Hepatobiliary Pancreat Dis Int, 4, 37

Singer, 2005, Brain death and organ damage: the modulating effects of nutrition, Transplantation, 80, 1363, 10.1097/01.tp.0000189710.92728.c5

Piratvisuth, 1995, Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation, Liver Transpl Surg, 1, 296, 10.1002/lt.500010505

Cameron, 2006, Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants, Ann Surg, 243, 748, 10.1097/01.sla.0000219669.84192.b3

Strasberg, 1994, Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation, Hepatology, 20, 829, 10.1002/hep.1840200410

http://www.eltr.org 2008

Yersiz, 1995, Correlation between donor age and the pattern of liver graft recovery after transplantation, Transplantation, 60, 790, 10.1097/00007890-199510270-00005

Organ Procurement and Transplantation Network http://www.optn.org/ar2007/904a_li.pdf 2008

Belzer, 1986, Organ preservation and transplantation, Prog Clin Biol Res, 224, 291

Cavallari, 2003, A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation, Liver Transpl, 9, 814, 10.1053/jlts.2003.50161

Belzer, 1992, The use of UW solution in clinical transplantation. A 4-year experience, Ann Surg, 215, 579, 10.1097/00000658-199206000-00004

Ben Mosbah, 2007, Addition of adenosine monophosphate-activated protein kinase activators to University of Wisconsin solution: a way of protecting rat steatotic livers, Liver Transpl, 13, 410, 10.1002/lt.21059

Howden, 2000, Liver preservation: a comparison of Celsior to colloid-free University of Wisconsin solution, Transplantation, 70, 1140, 10.1097/00007890-200010270-00002

Feng, 2007, Histidine-tryptophan-ketoglutarate solution vs. University of Wisconsin solution for liver transplantation: a systematic review, Liver Transpl, 13, 1125, 10.1002/lt.21208

Ben Mosbah, 2006, Preservation of steatotic livers in IGL-1 solution, Liver Transpl, 12, 1215, 10.1002/lt.20788

Pedotti, 2004, A comparative prospective study of two available solutions for kidney and liver preservation, Transplantation, 77, 1540, 10.1097/01.TP.0000132278.00441.CF

Eghtesad, 2006, Preservation solutions in liver transplantation: what are the options?, Liver Transpl, 12, 196, 10.1002/lt.20698

Verran, 2003, Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation, Liver Transpl, 9, 500, 10.1053/jlts.2003.50099

McCormack, 2007, Use of severely steatotic grafts in liver transplantation: a matched case-control study, Ann Surg, 246, 940, 10.1097/SLA.0b013e31815c2a3f

Fishbein, 1997, Use of livers with microvesicular fat safely expands the donor pool, Transplantation, 64, 248, 10.1097/00007890-199707270-00012

Frankel, 2002, The optimal number of donor biopsy sites to evaluate liver histology for transplantation, Liver Transpl, 8, 1044, 10.1053/jlts.2002.36492

Urena, 1998, Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program, Transplant Proc, 30, 3288, 10.1016/S0041-1345(98)01033-1

Zamboni, 2001, Effect of macrovesicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation, Clin Transplant, 15, 53, 10.1034/j.1399-0012.2001.150109.x

Imber, 2002, Current practice regarding the use of fatty livers: a trans-Atlantic survey, Liver Transpl, 8, 545, 10.1053/jlts.2002.31747

Selzner, 2001, Fatty liver in liver transplantation and surgery, Semin Liver Dis, 21, 105, 10.1055/s-2001-12933

Ploeg, 1993, Risk factors for primary dysfunction after liver transplantation-a multivariate analysis, Transplantation, 55, 807, 10.1097/00007890-199304000-00024

D'Alessandro, 1991, The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation, Transplant Proc, 23, 1536

Canelo, 1999, Is a fatty liver dangerous for transplantation?, Transplant Proc, 31, 414, 10.1016/S0041-1345(98)01685-6

Clavien, 2007, Strategies for safer liver surgery and partial liver transplantation, N Engl J Med, 356, 1545, 10.1056/NEJMra065156

Taub, 2004, Liver regeneration: from myth to mechanism, Nat Rev Mol Cell Biol, 5, 836, 10.1038/nrm1489

Berenguer, 2002, Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients, Hepatology, 36, 202, 10.1053/jhep.2002.33993

Mutimer, 2006, Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus, Transplantation, 81, 7, 10.1097/01.tp.0000188619.30677.84

Wali, 2002, Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C, Gut, 51, 248, 10.1136/gut.51.2.248

Jimenez Romero, 1999, Use of octogenarian livers safely expands the donor pool, Transplantation, 68, 572, 10.1097/00007890-199908270-00021

Nardo, 2004, Liver transplantation from donors aged 80 years and over: pushing the limit, Am J Transplant, 4, 1139, 10.1111/j.1600-6143.2004.00472.x

Diamond, 2007, Impact of graft type on outcome in pediatric liver transplantation: a report from Studies of Pediatric Liver Transplantation (SPLIT), Ann Surg, 246, 301, 10.1097/SLA.0b013e3180caa415

Vargas, 1999, Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts, Gastroenterology, 117, 149, 10.1016/S0016-5085(99)70561-5

Velidedeoglu, 2002, The outcome of liver grafts procured from hepatitis C-positive donors, Transplantation, 73, 582, 10.1097/00007890-200202270-00018

Freeman, 1999, Outcome of transplantation of organs procured from bacteremic donors, Transplantation, 68, 1107, 10.1097/00007890-199910270-00008

Cerutti, 2006, Bacterial- and fungal-positive cultures in organ donors: clinical impact in liver transplantation, Liver Transpl, 12, 1253, 10.1002/lt.20811

Lumbreras, 2001, Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients, Clin Infect Dis, 33, 722, 10.1086/322599

Lopez-Navidad, 1997, Successful transplantation of organs retrieved from donors with bacterial meningitis, Transplantation, 64, 365, 10.1097/00007890-199707270-00033

Kauffman, 2002, Transplant tumor registry: donors with central nervous system tumors, Transplantation, 73, 579, 10.1097/00007890-200202270-00017

Kauffman, 2000, First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer, Transplantation, 70, 1747, 10.1097/00007890-200012270-00014

Buell, 2006, How can donors with a previous malignancy be evaluated? Donors with central nervous system malignancies: are they truly safe?, J Hepatol, 45, 503, 10.1016/j.jhep.2006.07.019

http://ec.europa.eu/health. 2008

Vignot, 2005, mTOR-targeted therapy of cancer with rapamycin derivatives, Ann Oncol, 16, 525, 10.1093/annonc/mdi113

Burroughs, 2006, 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome, Lancet, 367, 225, 10.1016/S0140-6736(06)68033-1

Wilms, 2006, Long-term outcome of split liver transplantation using right extended grafts in adulthood: a matched pair analysis, Ann Surg, 244, 865, 10.1097/01.sla.0000247254.76747.f3

Renz, 2004, Split-liver transplantation in the United States: outcomes of a national survey, Ann Surg, 239, 172, 10.1097/01.sla.0000109150.89438.bd

Burdelski, 2005, What lessons have we learned in pediatric liver transplantation?, J Hepatol, 42, 28, 10.1016/j.jhep.2004.11.005

Sampietro, 2005, Extension of the adult hepatic allograft pool using split liver transplantation, Acta Gastroenterol Belg, 68, 369

Sommacale, 2000, In situ split liver transplantation for two adult recipients, Transplantation, 69, 1005, 10.1097/00007890-200003150-00060

Humar, 2001, Split liver transplantation for two adult recipients: an initial experience, Am J Transplant, 1, 366, 10.1034/j.1600-6143.2001.10413.x

Merion, 2004, Predicted lifetimes for adult and pediatric split liver versus adult whole liver transplant recipients, Am J Transplant, 4, 1792, 10.1111/j.1600-6143.2004.00594.x

Noujaim, 2003, Worth continuing doing ex situ liver graft splitting? A single-center analysis, Am J Transplant, 3, 318, 10.1034/j.1600-6143.2003.00047.x

Freeman, 2008, Liver and intestine transplantation in the United States, 1997-2006, Am J Transplant, 8, 958, 10.1111/j.1600-6143.2008.02174.x

Liu, 2006, Operative outcomes of adult-to-adult right lobe live donor liver transplantation: a comparative study with cadaveric whole-graft liver transplantation in a single center, Ann Surg, 243, 404, 10.1097/01.sla.0000201544.36473.a2

Chan, 2007, Toward current standards of donor right hepatectomy for adult-to-adult live donor liver transplantation through the experience of 200 cases, Ann Surg, 245, 110, 10.1097/01.sla.0000225085.82193.08

Berg, 2007, Improvement in survival associated with adult-to-adult living donor liver transplantation, Gastroenterology, 133, 1806, 10.1053/j.gastro.2007.09.004

Lo, 2007, Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma, Br J Surg, 94, 78, 10.1002/bjs.5528

Garcia-Retortillo, 2004, Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation, Hepatology, 40, 699, 10.1002/hep.20357

Terrault, 2007, Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation, Liver Transpl, 13, 122, 10.1002/lt.20995

Trotter, 2002, Adult-to-adult transplantation of the right hepatic lobe from a living donor, N Engl J Med, 346, 1074, 10.1056/NEJMra011629

Olthoff, 2005, Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL consortium, Ann Surg, 242, 314, 10.1097/01.sla.0000179646.37145.ef

Pomposelli, 2006, Improved survival after live donor adult liver transplantation (LDALT) using right lobe grafts: program experience and lessons learned, Am J Transplant, 6, 589, 10.1111/j.1600-6143.2005.01220.x

Concejero, 2008, Living donor liver transplantation for hepatocellular carcinoma: a single-center experience in Taiwan, Transplantation, 85, 398, 10.1097/TP.0b013e3181622ff8

Hwang, 2006, Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe, Liver Transpl, 12, 920, 10.1002/lt.20734

Fan, 2006, Live donor liver transplantation in adults, Transplantation, 82, 723, 10.1097/01.tp.0000235171.17287.f2

Trotter, 2006, Outcomes of donor evaluations for adult-to-adult right hepatic lobe living donor liver transplantation, Am J Transplant, 6, 1882, 10.1111/j.1600-6143.2006.01322.x

Kawasaki, 2003, Left lobe living donor liver transplantation: technical considerations, Transplant Proc, 35, 952, 10.1016/S0041-1345(03)00177-5

Soejima, 2008, Living donor liver transplantation using dual grafts from two donors: a feasible option to overcome small-for-size graft problems?, Am J Transplant, 8, 887, 10.1111/j.1600-6143.2008.02153.x

Boillot, 2002, Small-for-size partial liver graft in an adult recipient; a new transplant technique, Lancet, 359, 406, 10.1016/S0140-6736(02)07593-1

Chen, 2006, Successful adult-to-adult living donor liver transplantation combined with a cadaveric split left lateral segment, Liver Transpl, 12, 1557, 10.1002/lt.20879

Herlenius, 2004, Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry, Transplantation, 77, 64, 10.1097/01.TP.0000092307.98347.CB

Yamamoto, 2007, Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years, Am J Transplant, 7, 2597, 10.1111/j.1600-6143.2007.01969.x

Inomata, 2007, Whole-liver graft without the retrohepatic inferior vena cava for sequential (domino) living donor liver transplantation, Am J Transplant, 7, 1629, 10.1111/j.1600-6143.2007.01828.x

Takei, 2007, Transthyretin-derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver, Liver Transpl, 13, 215, 10.1002/lt.20954

Stangou, 2005, Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation, N Engl J Med, 352, 2356, 10.1056/NEJM200506023522219

http://www.fapwtr.org 2008

Deshpande, 2006, Can non-heart-beating donors replace cadaveric heart-beating liver donors?, J Hepatol, 45, 499, 10.1016/j.jhep.2006.07.018

Suarez, 2008, Biliary complications after liver transplantation from Maastricht category-2 non-heart-beating donors, Transplantation, 85, 9, 10.1097/01.tp.0000297945.83430.ce

Abt, 2004, Survival following liver transplantation from non-heart-beating donors, Ann Surg, 239, 87, 10.1097/01.sla.0000103063.82181.2c

Muiesan, 2005, Single-center experience with liver transplantation from controlled non-heart beating donors: a viable source of grafts, Ann Surg, 242, 732, 10.1097/01.sla.0000186177.26112.d2

Monbaliu, 2005, Livers from non-heart-beating donors tolerate short periods of warm ischemia, Transplantation, 79, 1226, 10.1097/01.TP.0000153508.71684.99

Net, 2005, The effect of normothermic recirculation is mediated by ischemic preconditioning in NHBD liver transplantation, Am J Transplant, 5, 2385, 10.1111/j.1600-6143.2005.01052.x

Schaubel, 2008, The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality, Am J Transplant, 8, 419, 10.1111/j.1600-6143.2007.02086.x

Maluf, 2006, Utilization of extended donor criteria liver allograft: is the elevated risk of failure independent of the Model for End-Stage Liver Disease score of the recipient?, Transplantation, 82, 1653, 10.1097/01.tp.0000250571.41361.21

Belghiti, 1995, Transplantation for fulminant and subfulminant hepatic failure with preservation of portal and caval flow, Br J Surg, 82, 986, 10.1002/bjs.1800820741

Heidenhain, 2006, Retrograde reperfusion via vena cava lowers the risk of initial nonfunction but increases the risk of ischemic-type biliary lesions in liver transplantation-a randomized clinical trial, Transpl Int, 19, 738, 10.1111/j.1432-2277.2006.00347.x

Polak, 2006, The sequence of revascularization in liver transplantation: it does make a difference, Liver Transpl, 12, 1566, 10.1002/lt.20797

Noun, 1997, Appraisal of the order of revascularization in human liver grafting: a controlled study, J Am Coll Surg, 185, 70, 10.1016/S1072-7515(97)00004-5

Dahm, 2005, Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications, Am J Transplant, 5, 2605, 10.1111/j.1600-6143.2005.01081.x

Suehiro, 2005, Effect of intraportal infusion to improve small for size graft injury in living donor adult liver transplantation, Transpl Int, 18, 923, 10.1111/j.1432-2277.2005.00159.x

Camus, 2006, Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation, Intensive Care Med, 32, 1817, 10.1007/s00134-006-0340-1

Berenguer, 2005, What determines the natural history of recurrent hepatitis C after liver transplantation?, J Hepatol, 42, 448, 10.1016/j.jhep.2005.01.011

Cameron, 2006, Effect of nonviral factors on hepatitis C recurrence after liver transplantation, Ann Surg, 244, 563

Ghobrial, 2001, A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients, Ann Surg, 234, 384, 10.1097/00000658-200109000-00012

Arenas, 2003, The use of hepatitis C-infected grafts in liver transplantation, Liver Transpl, 9, S48, 10.1053/jlts.2003.50252

Saab, 2003, Hepatitis C positive grafts may be used in orthotopic liver transplantation: a matched analysis, Am J Transplant, 3, 1167, 10.1034/j.1600-6143.2003.00189.x

Saab, 2003, Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation, Liver Transpl, 9, 1053, 10.1053/jlts.2003.50208

Rosen, 2003, Validation and refinement of survival models for liver retransplantation, Hepatology, 38, 460, 10.1053/jhep.2003.50328